A 2019 systematic critique of a randomized controlled trial evaluating the success of intravenous ketamine for discomfort relief in Serious refractory discomfort concluded that ketamine delivers sizeable quick-time period analgesic benefit in these individuals, having said that larger, multicenter scientific tests with for a longer period follow-u